Karyopherin a2 May Be Prognostic Indicator in Renal Cell Carcinoma

Researchers theorize that KPNA2 expression could be used in the future to stratify risk groups among patients with renal cell carcinoma (RCC).

from Latest articles from Cancer Therapy Advisor News https://ift.tt/2G0MeLM